Neuroendocrine Tumor Drug Market - Global Outlook and Forecast 2021-2027

Neuroendocrine Tumor Drug Market - Global Outlook and Forecast 2021-2027

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Neuroendocrine Tumor Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Neuroendocrine Tumor Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Neuroendocrine Tumor Drug Overall Market Size
2.1 Global Neuroendocrine Tumor Drug Market Size: 2021 VS 2027
2.2 Global Neuroendocrine Tumor Drug Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Neuroendocrine Tumor Drug Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Neuroendocrine Tumor Drug Players in Global Market
3.2 Top Global Neuroendocrine Tumor Drug Companies Ranked by Revenue
3.3 Global Neuroendocrine Tumor Drug Revenue by Companies
3.4 Global Neuroendocrine Tumor Drug Sales by Companies
3.5 Global Neuroendocrine Tumor Drug Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Neuroendocrine Tumor Drug Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Neuroendocrine Tumor Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Neuroendocrine Tumor Drug Players in Global Market
3.8.1 List of Global Tier 1 Neuroendocrine Tumor Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Neuroendocrine Tumor Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Neuroendocrine Tumor Drug Market Size Markets, 2021 & 2027
4.1.2 mTOR Protein Inhibitors
4.1.3 Tyrosine Kinase 3 Inhibitors
4.1.4 Somatostatin Receptor Antagonists
4.1.5 Growth Hormone Releasing Factor Antagonists
4.1.6 Somatostatin Receptor Agonists
4.1.7 Others
4.2 By Type - Global Neuroendocrine Tumor Drug Revenue & Forecasts
4.2.1 By Type - Global Neuroendocrine Tumor Drug Revenue, 2016-2021
4.2.2 By Type - Global Neuroendocrine Tumor Drug Revenue, 2022-2027
4.2.3 By Type - Global Neuroendocrine Tumor Drug Revenue Market Share, 2016-2027
4.3 By Type - Global Neuroendocrine Tumor Drug Sales & Forecasts
4.3.1 By Type - Global Neuroendocrine Tumor Drug Sales, 2016-2021
4.3.2 By Type - Global Neuroendocrine Tumor Drug Sales, 2022-2027
4.3.3 By Type - Global Neuroendocrine Tumor Drug Sales Market Share, 2016-2027
4.4 By Type - Global Neuroendocrine Tumor Drug Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Neuroendocrine Tumor Drug Market Size, 2021 & 2027
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Neuroendocrine Tumor Drug Revenue & Forecasts
5.2.1 By Application - Global Neuroendocrine Tumor Drug Revenue, 2016-2021
5.2.2 By Application - Global Neuroendocrine Tumor Drug Revenue, 2022-2027
5.2.3 By Application - Global Neuroendocrine Tumor Drug Revenue Market Share, 2016-2027
5.3 By Application - Global Neuroendocrine Tumor Drug Sales & Forecasts
5.3.1 By Application - Global Neuroendocrine Tumor Drug Sales, 2016-2021
5.3.2 By Application - Global Neuroendocrine Tumor Drug Sales, 2022-2027
5.3.3 By Application - Global Neuroendocrine Tumor Drug Sales Market Share, 2016-2027
5.4 By Application - Global Neuroendocrine Tumor Drug Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Neuroendocrine Tumor Drug Market Size, 2021 & 2027
6.2 By Region - Global Neuroendocrine Tumor Drug Revenue & Forecasts
6.2.1 By Region - Global Neuroendocrine Tumor Drug Revenue, 2016-2021
6.2.2 By Region - Global Neuroendocrine Tumor Drug Revenue, 2022-2027
6.2.3 By Region - Global Neuroendocrine Tumor Drug Revenue Market Share, 2016-2027
6.3 By Region - Global Neuroendocrine Tumor Drug Sales & Forecasts
6.3.1 By Region - Global Neuroendocrine Tumor Drug Sales, 2016-2021
6.3.2 By Region - Global Neuroendocrine Tumor Drug Sales, 2022-2027
6.3.3 By Region - Global Neuroendocrine Tumor Drug Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Neuroendocrine Tumor Drug Revenue, 2016-2027
6.4.2 By Country - North America Neuroendocrine Tumor Drug Sales, 2016-2027
6.4.3 US Neuroendocrine Tumor Drug Market Size, 2016-2027
6.4.4 Canada Neuroendocrine Tumor Drug Market Size, 2016-2027
6.4.5 Mexico Neuroendocrine Tumor Drug Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Neuroendocrine Tumor Drug Revenue, 2016-2027
6.5.2 By Country - Europe Neuroendocrine Tumor Drug Sales, 2016-2027
6.5.3 Germany Neuroendocrine Tumor Drug Market Size, 2016-2027
6.5.4 France Neuroendocrine Tumor Drug Market Size, 2016-2027
6.5.5 U.K. Neuroendocrine Tumor Drug Market Size, 2016-2027
6.5.6 Italy Neuroendocrine Tumor Drug Market Size, 2016-2027
6.5.7 Russia Neuroendocrine Tumor Drug Market Size, 2016-2027
6.5.8 Nordic Countries Neuroendocrine Tumor Drug Market Size, 2016-2027
6.5.9 Benelux Neuroendocrine Tumor Drug Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Neuroendocrine Tumor Drug Revenue, 2016-2027
6.6.2 By Region - Asia Neuroendocrine Tumor Drug Sales, 2016-2027
6.6.3 China Neuroendocrine Tumor Drug Market Size, 2016-2027
6.6.4 Japan Neuroendocrine Tumor Drug Market Size, 2016-2027
6.6.5 South Korea Neuroendocrine Tumor Drug Market Size, 2016-2027
6.6.6 Southeast Asia Neuroendocrine Tumor Drug Market Size, 2016-2027
6.6.7 India Neuroendocrine Tumor Drug Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Neuroendocrine Tumor Drug Revenue, 2016-2027
6.7.2 By Country - South America Neuroendocrine Tumor Drug Sales, 2016-2027
6.7.3 Brazil Neuroendocrine Tumor Drug Market Size, 2016-2027
6.7.4 Argentina Neuroendocrine Tumor Drug Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Neuroendocrine Tumor Drug Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Neuroendocrine Tumor Drug Sales, 2016-2027
6.8.3 Turkey Neuroendocrine Tumor Drug Market Size, 2016-2027
6.8.4 Israel Neuroendocrine Tumor Drug Market Size, 2016-2027
6.8.5 Saudi Arabia Neuroendocrine Tumor Drug Market Size, 2016-2027
6.8.6 UAE Neuroendocrine Tumor Drug Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Eisai
7.1.1 Eisai Corporate Summary
7.1.2 Eisai Business Overview
7.1.3 Eisai Neuroendocrine Tumor Drug Major Product Offerings
7.1.4 Eisai Neuroendocrine Tumor Drug Sales and Revenue in Global (2016-2021)
7.1.5 Eisai Key News
7.2 Exelixis, Inc.
7.2.1 Exelixis, Inc. Corporate Summary
7.2.2 Exelixis, Inc. Business Overview
7.2.3 Exelixis, Inc. Neuroendocrine Tumor Drug Major Product Offerings
7.2.4 Exelixis, Inc. Neuroendocrine Tumor Drug Sales and Revenue in Global (2016-2021)
7.2.5 Exelixis, Inc. Key News
7.3 Foresee Pharmaceuticals, LLC
7.3.1 Foresee Pharmaceuticals, LLC Corporate Summary
7.3.2 Foresee Pharmaceuticals, LLC Business Overview
7.3.3 Foresee Pharmaceuticals, LLC Neuroendocrine Tumor Drug Major Product Offerings
7.3.4 Foresee Pharmaceuticals, LLC Neuroendocrine Tumor Drug Sales and Revenue in Global (2016-2021)
7.3.5 Foresee Pharmaceuticals, LLC Key News
7.4 Hutchison MediPharma Limited
7.4.1 Hutchison MediPharma Limited Corporate Summary
7.4.2 Hutchison MediPharma Limited Business Overview
7.4.3 Hutchison MediPharma Limited Neuroendocrine Tumor Drug Major Product Offerings
7.4.4 Hutchison MediPharma Limited Neuroendocrine Tumor Drug Sales and Revenue in Global (2016-2021)
7.4.5 Hutchison MediPharma Limited Key News
7.5 Intezyne, Inc
7.5.1 Intezyne, Inc Corporate Summary
7.5.2 Intezyne, Inc Business Overview
7.5.3 Intezyne, Inc Neuroendocrine Tumor Drug Major Product Offerings
7.5.4 Intezyne, Inc Neuroendocrine Tumor Drug Sales and Revenue in Global (2016-2021)
7.5.5 Intezyne, Inc Key News
7.6 INVENT Pharmaceuticals, Inc.
7.6.1 INVENT Pharmaceuticals, Inc. Corporate Summary
7.6.2 INVENT Pharmaceuticals, Inc. Business Overview
7.6.3 INVENT Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Major Product Offerings
7.6.4 INVENT Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Sales and Revenue in Global (2016-2021)
7.6.5 INVENT Pharmaceuticals, Inc. Key News
7.7 Ipsen S.A.
7.7.1 Ipsen S.A. Corporate Summary
7.7.2 Ipsen S.A. Business Overview
7.7.3 Ipsen S.A. Neuroendocrine Tumor Drug Major Product Offerings
7.4.4 Ipsen S.A. Neuroendocrine Tumor Drug Sales and Revenue in Global (2016-2021)
7.7.5 Ipsen S.A. Key News
7.8 Jiangsu Hengrui Medicine Co., Ltd.
7.8.1 Jiangsu Hengrui Medicine Co., Ltd. Corporate Summary
7.8.2 Jiangsu Hengrui Medicine Co., Ltd. Business Overview
7.8.3 Jiangsu Hengrui Medicine Co., Ltd. Neuroendocrine Tumor Drug Major Product Offerings
7.8.4 Jiangsu Hengrui Medicine Co., Ltd. Neuroendocrine Tumor Drug Sales and Revenue in Global (2016-2021)
7.8.5 Jiangsu Hengrui Medicine Co., Ltd. Key News
7.9 Karyopharm Therapeutics, Inc.
7.9.1 Karyopharm Therapeutics, Inc. Corporate Summary
7.9.2 Karyopharm Therapeutics, Inc. Business Overview
7.9.3 Karyopharm Therapeutics, Inc. Neuroendocrine Tumor Drug Major Product Offerings
7.9.4 Karyopharm Therapeutics, Inc. Neuroendocrine Tumor Drug Sales and Revenue in Global (2016-2021)
7.9.5 Karyopharm Therapeutics, Inc. Key News
7.10 Lexicon Pharmaceuticals, Inc.
7.10.1 Lexicon Pharmaceuticals, Inc. Corporate Summary
7.10.2 Lexicon Pharmaceuticals, Inc. Business Overview
7.10.3 Lexicon Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Major Product Offerings
7.10.4 Lexicon Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Sales and Revenue in Global (2016-2021)
7.10.5 Lexicon Pharmaceuticals, Inc. Key News
7.11 Midatech Pharma Plc .
7.11.1 Midatech Pharma Plc . Corporate Summary
7.11.2 Midatech Pharma Plc . Neuroendocrine Tumor Drug Business Overview
7.11.3 Midatech Pharma Plc . Neuroendocrine Tumor Drug Major Product Offerings
7.11.4 Midatech Pharma Plc . Neuroendocrine Tumor Drug Sales and Revenue in Global (2016-2021)
7.11.5 Midatech Pharma Plc . Key News
7.12 Millennium Pharmaceuticals, Inc.
7.12.1 Millennium Pharmaceuticals, Inc. Corporate Summary
7.12.2 Millennium Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Business Overview
7.12.3 Millennium Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Major Product Offerings
7.12.4 Millennium Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Sales and Revenue in Global (2016-2021)
7.12.5 Millennium Pharmaceuticals, Inc. Key News
7.13 MolMed S.p.A.
7.13.1 MolMed S.p.A. Corporate Summary
7.13.2 MolMed S.p.A. Neuroendocrine Tumor Drug Business Overview
7.13.3 MolMed S.p.A. Neuroendocrine Tumor Drug Major Product Offerings
7.13.4 MolMed S.p.A. Neuroendocrine Tumor Drug Sales and Revenue in Global (2016-2021)
7.13.5 MolMed S.p.A. Key News
7.14 Northwest Biotherapeutics, Inc.
7.14.1 Northwest Biotherapeutics, Inc. Corporate Summary
7.14.2 Northwest Biotherapeutics, Inc. Business Overview
7.14.3 Northwest Biotherapeutics, Inc. Neuroendocrine Tumor Drug Major Product Offerings
7.14.4 Northwest Biotherapeutics, Inc. Neuroendocrine Tumor Drug Sales and Revenue in Global (2016-2021)
7.14.5 Northwest Biotherapeutics, Inc. Key News
7.15 Novartis AG
7.15.1 Novartis AG Corporate Summary
7.15.2 Novartis AG Business Overview
7.15.3 Novartis AG Neuroendocrine Tumor Drug Major Product Offerings
7.15.4 Novartis AG Neuroendocrine Tumor Drug Sales and Revenue in Global (2016-2021)
7.15.5 Novartis AG Key News
7.16 OctreoPharm Sciences GmbH
7.16.1 OctreoPharm Sciences GmbH Corporate Summary
7.16.2 OctreoPharm Sciences GmbH Business Overview
7.16.3 OctreoPharm Sciences GmbH Neuroendocrine Tumor Drug Major Product Offerings
7.16.4 OctreoPharm Sciences GmbH Neuroendocrine Tumor Drug Sales and Revenue in Global (2016-2021)
7.16.5 OctreoPharm Sciences GmbH Key News
7.17 OXiGENE, Inc.
7.17.1 OXiGENE, Inc. Corporate Summary
7.17.2 OXiGENE, Inc. Business Overview
7.17.3 OXiGENE, Inc. Neuroendocrine Tumor Drug Major Product Offerings
7.17.4 OXiGENE, Inc. Neuroendocrine Tumor Drug Sales and Revenue in Global (2016-2021)
7.17.5 OXiGENE, Inc. Key News
8 Global Neuroendocrine Tumor Drug Production Capacity, Analysis
8.1 Global Neuroendocrine Tumor Drug Production Capacity, 2016-2027
8.2 Neuroendocrine Tumor Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Neuroendocrine Tumor Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Neuroendocrine Tumor Drug Supply Chain Analysis
10.1 Neuroendocrine Tumor Drug Industry Value Chain
10.2 Neuroendocrine Tumor Drug Upstream Market
10.3 Neuroendocrine Tumor Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Neuroendocrine Tumor Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Neuroendocrine Tumor Drug in Global Market
Table 2. Top Neuroendocrine Tumor Drug Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Neuroendocrine Tumor Drug Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Neuroendocrine Tumor Drug Revenue Share by Companies, 2016-2021
Table 5. Global Neuroendocrine Tumor Drug Sales by Companies, (K Pcs), 2016-2021
Table 6. Global Neuroendocrine Tumor Drug Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Neuroendocrine Tumor Drug Price (2016-2021) & (USD/Pcs)
Table 8. Global Manufacturers Neuroendocrine Tumor Drug Product Type
Table 9. List of Global Tier 1 Neuroendocrine Tumor Drug Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Neuroendocrine Tumor Drug Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Neuroendocrine Tumor Drug Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Global Neuroendocrine Tumor Drug Revenue (US$, Mn), 2016-2021
Table 13. By Type - Global Neuroendocrine Tumor Drug Revenue (US$, Mn), 2022-2027
Table 14. By Type - Global Neuroendocrine Tumor Drug Sales (K Pcs), 2016-2021
Table 15. By Type - Global Neuroendocrine Tumor Drug Sales (K Pcs), 2022-2027
Table 16. By Application - Global Neuroendocrine Tumor Drug Revenue, (US$, Mn), 2021 VS 2027
Table 17. By Application - Global Neuroendocrine Tumor Drug Revenue (US$, Mn), 2016-2021
Table 18. By Application - Global Neuroendocrine Tumor Drug Revenue (US$, Mn), 2022-2027
Table 19. By Application - Global Neuroendocrine Tumor Drug Sales (K Pcs), 2016-2021
Table 20. By Application - Global Neuroendocrine Tumor Drug Sales (K Pcs), 2022-2027
Table 21. By Region - Global Neuroendocrine Tumor Drug Revenue, (US$, Mn), 2021 VS 2027
Table 22. By Region - Global Neuroendocrine Tumor Drug Revenue (US$, Mn), 2016-2021
Table 23. By Region - Global Neuroendocrine Tumor Drug Revenue (US$, Mn), 2022-2027
Table 24. By Region - Global Neuroendocrine Tumor Drug Sales (K Pcs), 2016-2021
Table 25. By Region - Global Neuroendocrine Tumor Drug Sales (K Pcs), 2022-2027
Table 26. By Country - North America Neuroendocrine Tumor Drug Revenue, (US$, Mn), 2016-2021
Table 27. By Country - North America Neuroendocrine Tumor Drug Revenue, (US$, Mn), 2022-2027
Table 28. By Country - North America Neuroendocrine Tumor Drug Sales, (K Pcs), 2016-2021
Table 29. By Country - North America Neuroendocrine Tumor Drug Sales, (K Pcs), 2022-2027
Table 30. By Country - Europe Neuroendocrine Tumor Drug Revenue, (US$, Mn), 2016-2021
Table 31. By Country - Europe Neuroendocrine Tumor Drug Revenue, (US$, Mn), 2022-2027
Table 32. By Country - Europe Neuroendocrine Tumor Drug Sales, (K Pcs), 2016-2021
Table 33. By Country - Europe Neuroendocrine Tumor Drug Sales, (K Pcs), 2022-2027
Table 34. By Region - Asia Neuroendocrine Tumor Drug Revenue, (US$, Mn), 2016-2021
Table 35. By Region - Asia Neuroendocrine Tumor Drug Revenue, (US$, Mn), 2022-2027
Table 36. By Region - Asia Neuroendocrine Tumor Drug Sales, (K Pcs), 2016-2021
Table 37. By Region - Asia Neuroendocrine Tumor Drug Sales, (K Pcs), 2022-2027
Table 38. By Country - South America Neuroendocrine Tumor Drug Revenue, (US$, Mn), 2016-2021
Table 39. By Country - South America Neuroendocrine Tumor Drug Revenue, (US$, Mn), 2022-2027
Table 40. By Country - South America Neuroendocrine Tumor Drug Sales, (K Pcs), 2016-2021
Table 41. By Country - South America Neuroendocrine Tumor Drug Sales, (K Pcs), 2022-2027
Table 42. By Country - Middle East & Africa Neuroendocrine Tumor Drug Revenue, (US$, Mn), 2016-2021
Table 43. By Country - Middle East & Africa Neuroendocrine Tumor Drug Revenue, (US$, Mn), 2022-2027
Table 44. By Country - Middle East & Africa Neuroendocrine Tumor Drug Sales, (K Pcs), 2016-2021
Table 45. By Country - Middle East & Africa Neuroendocrine Tumor Drug Sales, (K Pcs), 2022-2027
Table 46. Eisai Corporate Summary
Table 47. Eisai Neuroendocrine Tumor Drug Product Offerings
Table 48. Eisai Neuroendocrine Tumor Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2016-2021)
Table 49. Exelixis, Inc. Corporate Summary
Table 50. Exelixis, Inc. Neuroendocrine Tumor Drug Product Offerings
Table 51. Exelixis, Inc. Neuroendocrine Tumor Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2016-2021)
Table 52. Foresee Pharmaceuticals, LLC Corporate Summary
Table 53. Foresee Pharmaceuticals, LLC Neuroendocrine Tumor Drug Product Offerings
Table 54. Foresee Pharmaceuticals, LLC Neuroendocrine Tumor Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2016-2021)
Table 55. Hutchison MediPharma Limited Corporate Summary
Table 56. Hutchison MediPharma Limited Neuroendocrine Tumor Drug Product Offerings
Table 57. Hutchison MediPharma Limited Neuroendocrine Tumor Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2016-2021)
Table 58. Intezyne, Inc Corporate Summary
Table 59. Intezyne, Inc Neuroendocrine Tumor Drug Product Offerings
Table 60. Intezyne, Inc Neuroendocrine Tumor Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2016-2021)
Table 61. INVENT Pharmaceuticals, Inc. Corporate Summary
Table 62. INVENT Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Product Offerings
Table 63. INVENT Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2016-2021)
Table 64. Ipsen S.A. Corporate Summary
Table 65. Ipsen S.A. Neuroendocrine Tumor Drug Product Offerings
Table 66. Ipsen S.A. Neuroendocrine Tumor Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2016-2021)
Table 67. Jiangsu Hengrui Medicine Co., Ltd. Corporate Summary
Table 68. Jiangsu Hengrui Medicine Co., Ltd. Neuroendocrine Tumor Drug Product Offerings
Table 69. Jiangsu Hengrui Medicine Co., Ltd. Neuroendocrine Tumor Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2016-2021)
Table 70. Karyopharm Therapeutics, Inc. Corporate Summary
Table 71. Karyopharm Therapeutics, Inc. Neuroendocrine Tumor Drug Product Offerings
Table 72. Karyopharm Therapeutics, Inc. Neuroendocrine Tumor Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2016-2021)
Table 73. Lexicon Pharmaceuticals, Inc. Corporate Summary
Table 74. Lexicon Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Product Offerings
Table 75. Lexicon Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2016-2021)
Table 76. Midatech Pharma Plc . Corporate Summary
Table 77. Midatech Pharma Plc . Neuroendocrine Tumor Drug Product Offerings
Table 78. Midatech Pharma Plc . Neuroendocrine Tumor Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2016-2021)
Table 79. Millennium Pharmaceuticals, Inc. Corporate Summary
Table 80. Millennium Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Product Offerings
Table 81. Millennium Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2016-2021)
Table 82. MolMed S.p.A. Corporate Summary
Table 83. MolMed S.p.A. Neuroendocrine Tumor Drug Product Offerings
Table 84. MolMed S.p.A. Neuroendocrine Tumor Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2016-2021)
Table 85. Northwest Biotherapeutics, Inc. Corporate Summary
Table 86. Northwest Biotherapeutics, Inc. Neuroendocrine Tumor Drug Product Offerings
Table 87. Northwest Biotherapeutics, Inc. Neuroendocrine Tumor Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2016-2021)
Table 88. Novartis AG Corporate Summary
Table 89. Novartis AG Neuroendocrine Tumor Drug Product Offerings
Table 90. Novartis AG Neuroendocrine Tumor Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2016-2021)
Table 91. OctreoPharm Sciences GmbH Corporate Summary
Table 92. OctreoPharm Sciences GmbH Neuroendocrine Tumor Drug Product Offerings
Table 93. OctreoPharm Sciences GmbH Neuroendocrine Tumor Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2016-2021)
Table 94. OXiGENE, Inc. Corporate Summary
Table 95. OXiGENE, Inc. Neuroendocrine Tumor Drug Product Offerings
Table 96. OXiGENE, Inc. Neuroendocrine Tumor Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2016-2021)
Table 97. Neuroendocrine Tumor Drug Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2019-2021 (K Pcs)
Table 98. Global Neuroendocrine Tumor Drug Capacity Market Share of Key Manufacturers, 2019-2021
Table 99. Global Neuroendocrine Tumor Drug Production by Region, 2016-2021 (K Pcs)
Table 100. Global Neuroendocrine Tumor Drug Production by Region, 2022-2027 (K Pcs)
Table 101. Neuroendocrine Tumor Drug Market Opportunities & Trends in Global Market
Table 102. Neuroendocrine Tumor Drug Market Drivers in Global Market
Table 103. Neuroendocrine Tumor Drug Market Restraints in Global Market
Table 104. Neuroendocrine Tumor Drug Raw Materials
Table 105. Neuroendocrine Tumor Drug Raw Materials Suppliers in Global Market
Table 106. Typical Neuroendocrine Tumor Drug Downstream
Table 107. Neuroendocrine Tumor Drug Downstream Clients in Global Market
Table 108. Neuroendocrine Tumor Drug Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Neuroendocrine Tumor Drug Segment by Type
Figure 2. Neuroendocrine Tumor Drug Segment by Application
Figure 3. Global Neuroendocrine Tumor Drug Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Neuroendocrine Tumor Drug Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Neuroendocrine Tumor Drug Revenue, 2016-2027 (US$, Mn)
Figure 7. Neuroendocrine Tumor Drug Sales in Global Market: 2016-2027 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Neuroendocrine Tumor Drug Revenue in 2020
Figure 9. By Type - Global Neuroendocrine Tumor Drug Sales Market Share, 2016-2027
Figure 10. By Type - Global Neuroendocrine Tumor Drug Revenue Market Share, 2016-2027
Figure 11. By Type - Global Neuroendocrine Tumor Drug Price (USD/Pcs), 2016-2027
Figure 12. By Application - Global Neuroendocrine Tumor Drug Sales Market Share, 2016-2027
Figure 13. By Application - Global Neuroendocrine Tumor Drug Revenue Market Share, 2016-2027
Figure 14. By Application - Global Neuroendocrine Tumor Drug Price (USD/Pcs), 2016-2027
Figure 15. By Region - Global Neuroendocrine Tumor Drug Sales Market Share, 2016-2027
Figure 16. By Region - Global Neuroendocrine Tumor Drug Revenue Market Share, 2016-2027
Figure 17. By Country - North America Neuroendocrine Tumor Drug Revenue Market Share, 2016-2027
Figure 18. By Country - North America Neuroendocrine Tumor Drug Sales Market Share, 2016-2027
Figure 19. US Neuroendocrine Tumor Drug Revenue, (US$, Mn), 2016-2027
Figure 20. Canada Neuroendocrine Tumor Drug Revenue, (US$, Mn), 2016-2027
Figure 21. Mexico Neuroendocrine Tumor Drug Revenue, (US$, Mn), 2016-2027
Figure 22. By Country - Europe Neuroendocrine Tumor Drug Revenue Market Share, 2016-2027
Figure 23. By Country - Europe Neuroendocrine Tumor Drug Sales Market Share, 2016-2027
Figure 24. Germany Neuroendocrine Tumor Drug Revenue, (US$, Mn), 2016-2027
Figure 25. France Neuroendocrine Tumor Drug Revenue, (US$, Mn), 2016-2027
Figure 26. U.K. Neuroendocrine Tumor Drug Revenue, (US$, Mn), 2016-2027
Figure 27. Italy Neuroendocrine Tumor Drug Revenue, (US$, Mn), 2016-2027
Figure 28. Russia Neuroendocrine Tumor Drug Revenue, (US$, Mn), 2016-2027
Figure 29. Nordic Countries Neuroendocrine Tumor Drug Revenue, (US$, Mn), 2016-2027
Figure 30. Benelux Neuroendocrine Tumor Drug Revenue, (US$, Mn), 2016-2027
Figure 31. By Region - Asia Neuroendocrine Tumor Drug Revenue Market Share, 2016-2027
Figure 32. By Region - Asia Neuroendocrine Tumor Drug Sales Market Share, 2016-2027
Figure 33. China Neuroendocrine Tumor Drug Revenue, (US$, Mn), 2016-2027
Figure 34. Japan Neuroendocrine Tumor Drug Revenue, (US$, Mn), 2016-2027
Figure 35. South Korea Neuroendocrine Tumor Drug Revenue, (US$, Mn), 2016-2027
Figure 36. Southeast Asia Neuroendocrine Tumor Drug Revenue, (US$, Mn), 2016-2027
Figure 37. India Neuroendocrine Tumor Drug Revenue, (US$, Mn), 2016-2027
Figure 38. By Country - South America Neuroendocrine Tumor Drug Revenue Market Share, 2016-2027
Figure 39. By Country - South America Neuroendocrine Tumor Drug Sales Market Share, 2016-2027
Figure 40. Brazil Neuroendocrine Tumor Drug Revenue, (US$, Mn), 2016-2027
Figure 41. Argentina Neuroendocrine Tumor Drug Revenue, (US$, Mn), 2016-2027
Figure 42. By Country - Middle East & Africa Neuroendocrine Tumor Drug Revenue Market Share, 2016-2027
Figure 43. By Country - Middle East & Africa Neuroendocrine Tumor Drug Sales Market Share, 2016-2027
Figure 44. Turkey Neuroendocrine Tumor Drug Revenue, (US$, Mn), 2016-2027
Figure 45. Israel Neuroendocrine Tumor Drug Revenue, (US$, Mn), 2016-2027
Figure 46. Saudi Arabia Neuroendocrine Tumor Drug Revenue, (US$, Mn), 2016-2027
Figure 47. UAE Neuroendocrine Tumor Drug Revenue, (US$, Mn), 2016-2027
Figure 48. Global Neuroendocrine Tumor Drug Production Capacity (K Pcs), 2016-2027
Figure 49. The Percentage of Production Neuroendocrine Tumor Drug by Region, 2020 VS 2027
Figure 50. Neuroendocrine Tumor Drug Industry Value Chain
Figure 51. Marketing Channels

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global 5-Fluorouracil Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 76

The global 5-Fluorouracil market was valued at US$ 283 million in 2023 and is anticipated to reach US$ 487.9 million by 2030, witnessing a CAGR of 4.3% during The forecast period 2024-2030. North American market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by ......

Global Carboplatin Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global Carboplatin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % d......

Global Neutropenia Drugs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 96

The global Neutropenia Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated to increa......

Global Small Molecule Cancer Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Small Molecule Cancer Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated ......

Global Capecitabine Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 80

Capecitabine is an orally-administered chemotherapeutic agent used in The treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in The tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects include blood clotting problems, allergic reactions, heart problems, and low blo......

Global Oxaliplatin Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104

Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy The third stage colon cancer after resecting primary tumor completely. In this report, only The finished drug is covered, exclude API. The global Oxaliplatin market was valued at US$ 897.5 million in 2023 and is anticipated to reach US$ 1641.5 million by 2030, witnessing a CAGR of 8.9% duri......

Global Cancer Treatment Drugs Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158

According to our LPI (LP Information) latest study, the global Cancer Treatment Drugs market size was valued at US$ 174990 million in 2023. With growing demand in downstream market, the Cancer Treatment Drugs is forecast to a readjusted size of US$ 322540 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Cancer Treatment Drugs market. Cancer Treatment Drugs are expected to show stable growth in the future market. H......

Global Capecitabine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93

According to our LPI (LP Information) latest study, the global Capecitabine market size was valued at US$ 1003.9 million in 2023. With growing demand in downstream market, the Capecitabine is forecast to a readjusted size of US$ 975.1 million by 2030 with a CAGR of -0.4% during review period. The research report highlights the growth potential of the global Capecitabine market. Capecitabine are expected to show stable growth in the future market. However, product differentiation, reducin......

Global Methotrexate Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95

According to our LPI (LP Information) latest study, the global Methotrexate market size was valued at US$ 506 million in 2023. With growing demand in downstream market, the Methotrexate is forecast to a readjusted size of US$ 613.9 million by 2030 with a CAGR of 2.8% during review period. The research report highlights the growth potential of the global Methotrexate market. Methotrexate are expected to show stable growth in the future market. However, product differentiation, reducing co......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs